Vnitr Lek 2016, 62(12):1048

Korespondence ke článku. Charvát J. Kardiorenální syndrom - biomarkery a mediátory

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Korespondence ke článku. Charvát J. Kardiorenální syndrom - biomarkery a mediátory. Vnitr Lek. 2016;62(12):1048.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Braunwald E Heart disease. IV. Edition. Philadelphia: W. B. Saunders Comp. 1992, 471-475.
    2. Hurst's The Heart. 11. Edition. New York: Mc Graw-Hill 2004, 737-739.
    3. USP DI. 17. Edition. Volum I. US Pharmacop. Conv. Inc. 1997, 1265-1266.
    4. Komaja M, Folath F, Swedberg K et al. The EuroHeart Failure Survey program - a survey on quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003; 24: 464-474. Go to original source... Go to PubMed...
    5. Rosenberg J, Gustafsson F, Galatius S et al.: Cardiovas Drugs Ther 2005; 15: 301. Doi: 10.1007/s10557-005-3350-2. August 2005; 19: 301-306.
    6. Ascher AW Treatment of furosemide resistant oedema with metolazone. Clin Trials J 1974; 4: 134-139.
    7. Bamford JM Synergistic action of metazolane with "loop" diuretics. Brit Med J 1981; 283: 618.
    8. Jerie P, Pátek F Uľití triamterene při léčbě městnavé srdeční slabosti. Vnitř Lék 1969; 15: 1105-1112. Go to PubMed...
    9. Jerie P Behandlung der terapieresistenten Herzinsuffizienz. Schweiz Rundschau Med (PRAXIS) 1983; 72: 15-21. Go to PubMed...
    10. ©pinar J, Hradec J, ©pinarová L et al. Souhrn Doporučených postupů ESC pro diagnostiku a léčbu akutního a chronického srdečního selhání z roku 2016. Cor Vasa 2016; 58: 597-636. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.